We would love to hear your thoughts about our site and services, please take our survey here.
Its 100% Odyseus !!! Same droning on and just won't find something productive to do, so obvious that I've lost any respect for him. This is the guy who said he was a sophisticated investor now, he wouldn't but at 12p cos it was a huge drop to 10p and he felt FUM would end up raising money at 10p. Fair enough I thought it might happen too but wasn't innocent enough for that 20% drop to miss out on a 400% rise.
But more obvious is that he just keeps repeating the same negative story pretending he just musing the possibilities.
I agree - an overall uptick between now and 4 weeks time. Lot of fluctuating between now and then.
Agreed completely damo. I'd say EU is in the bag and deals/partnerships will push price up. That said the confirmation of EU may just create publicity and bring the crowd in to buy, doubt it but possible.
It is AIM so you never know, although Oil seems to be the fashionable share at the minute for the get rich quick brigade.
Hi Italian - You do know that you are replying to Liambooth aka Ody :)
You are far more patient than I am and while I'm at it have enjoyed your balanced commentary over the past while.
Ha ha - looks like Ody wasn't so gracious afterall. Just set up a new account as Liambooth. Same style of writing and just keeps repeating the same points in the hope of it sticking, exactly the same way as Ody did even when people agreed he repeated again to make sure his post was at the top. Seriously how bad minded and little do some people have to be to just do everything in their power (which is very little) to try and move a share price down.
This will exceed a pound and who knows from there, I told Ody/Liam he was crazy not to join at 13p that it was too much of a risk to miss out on rise for sake of trying to get in at 10-12.
Perversely I think yesterdays news has done the SP more harm than good. I read on a couple of other boards that our rise yesterday was due to the FDA news when in fact it is still rising form the European approval which is much bigger and more positive news. What happened yesterday was expected and priced in. My point being is that news of European approval has been lost on the herd, if news gets out that the rise is due to positive news about how small the US trial needs to be, well then its probably being viewed as rise complete and next news is 12 months away. We need to be advertising the fact that we don't need any news - we have EU approval - roll on the cash cow.
All that said I've no doubt the herd will continue to arrive here over the next few weeks as word gets around - hence totally confident now of an over £1 at some point soon and who the hell knows how high it will go - it is AIM afterall!!!
Funny to see the derampers back once SP goes back. That said we're 50% up approx from a year ago , I've already filtered ody - first person I've filtered after several years on this board and eatmyshorts looks to be in same category not because of his opinion but his comments are absolutely ......... with no insight whatsoever.
Anyway my take on this is that there is no leaks, no imminent news, no MM games but very simply someone building up their position prior to us getting news. This is not too surprising as the SP on almost all stocks rises when news on approvals is imminent, then a massive rise if it comes through and fall if not. In our case its a little different as not only are we waiting on approval news but a fundraise is also possible hence the slowness of our SP rise. If we were just waiting on approval with no possibility of a fundraise then I think we would be in the 30's or more as we were before when trial results were due.
For those who might rubbish my use of the word imminent - I am a LTH type investor unless a fundamental changes in the company so imminent for me is in the next 4-6 months.
Ahhh, what relief. For the first time since I joined the LSE website I have filtered someone's chat messages. What a pain in the 4ole, no longer listening to the same drivel :)
Obviously not aimed at you reflex but continuing on your thread ;)
Hmmmm Ody - I'm pretty sure I'm not wrong.
The below text is taken from your post in October.
"2004 - nearly £1 a share. Dec 2009 before Phase 3 "failure" 35p a share. After phase 3 failure, 8p a share. May/June 2020, 26p a share. Sept - 12p a share. Today, 16p a share".
You were making a different point but all the same saying it went from 12p to 16p in Sept / Oct. Well at least thats according to you and in fairness you do know an awful lot.
My thoughts exactly reflex & ndr.
The need to constantly reiterate the same point is baffling.
To be fair Ody you were also here when it hit sub 12 and you are the one always going on about percentages. If you bought then you would be sitting on 25% gain - not to mention the fact that it has been higher since that sub 12 level.
Anyway we're here for the long haul except you who don't have any shares of note. I still stick with my EU approval by July. My thought process is that this company who they have agreed terms with is waiting to see what the EU response is. Which I thought we might have some indication by now. The longer it goes on the more your possibility of dilution looks but I'll hold on regardless.
Hawkhead, do you not feel you loose credibility when you keep saying its going down or strong sell when in actual fact there has been no change and actually a rise in the last 12 months? It just seems completely pointless that you keep saying that with no shame to the fact that you have called it wrong everytime.
ndr to be fair they may say 277 days but I can tell you anyone in the business would be basing on a 12 month cycle and that is if it goes fairly straight forward i.e. no further trials but I guess that goes without saying. I said when the submission was made (July 2020) that July of 2021 would be my guess for approval which is Q3. We do need patience and maybe you will be right if they are actively reviewing it now as it says in the RNS. If it goes smooth we could get approval sooner but even then I would expect a few small question which could easily take 4-6 weeks to answer and then the same to review.
Idg I would be inclined to agree that funding is more probable but I will be disappointed if it happens. The reason ill be disappointed is that management could have foreseen this and raised money when in a stronger position which in turn would put them in a lot stronger position in current negotiations. My hope all along is that the reason they didn't raise money previously (as in the last 6 months). Is that they had a trick up their sleeve such as commercial partner, if im right all is forgiven. If they raise money at the last minute it doesn't look like good management but at same time would mean we could sail our own ship out to approval.
I honestly don't think we will knock viagra (or cilais ) off their perch but we don't need to. No doubt when we get clearance we would gain a nice percentage of their customers but there is a huge subset of people who can't take those medicines due to the side effects and getting those is enough to make this a ten bagger. I also feel if I had the balls to see this out completely I would be interested to see how many users who have no ED issues would use this solution over time. I for one would love to try it and I have no ED issues. This market could be enormous but again you would need the gonads to stay here for the long term. I don't see our solution being as 'strong' as the oral medications but again with no side effects we should be able to get clearance and get customers once it does work for 65% of the people.
All in all what is holding this SP back is the question around what comes first
- A commercial partner who pays for upcoming trials
- Or if we have to raise more money and hence dilute .
Everyone is waiting to see if the partner comes first and until that is confirmed the SP will just bob along but todays RNS while solid is obviously not a confirmation and this is what the market needs. A partner if credible also shows belief from other commercial entities which somewhat validates what they are doing.
LOL Ody - you previously said you bought these shares 10-15 years ago . Now its 20 years ago - much like your SP predications you can fairly change your view to suit your point.
Anyway you have been saying since June this will drift to 10-12p. Do you care to say when or will you be correct if it ever hits 11p? If thats the case then all the rampers were also correct as I believe it hit mid twenties at some point since June. Whereas we're still waiting for 11p.
So I await your answer as to when it will reach 11p. So far you've been saying it for 6 months but hasn't happened.
If timing didn't matter, I will say this, FUM will hit 50p - I just don't know when.
Ody - please don't do a trump in it and just spout things even when plainly not true. Where did I imply anything - please quote the post! I have always been consistent in saying EU approval was at least 12 months and the real money making this SP move knows that too.
I also always said we were likely to have EU questions big or small i.e. not a straight forward drop in application and away we go.
As for the rampers of which I am not one - yes it could take off any time now that is the nature of this stock and AIM in general. Just a matter of timing it and you really shouldn't act as though you are the owner of wisdom here - especially given that on percentage terms there is no one else on this board standing on a bigger loss than you.
Ody - Your level of arrogance at making sure you put everyone elses opinion down and the constant need to seek approval is a little bit unsettling. Even when no one is bothered to argue or listen to you - you still seek approval.
Anyway to answer your question.
1 - News on EMA submission - anyone in the know will not expect news before Christmas , I work in this area and I would not expect it and when you say that this indicates something about the submission questions being more medium level you are talking absolute rubbish. You must know that, it is likely they have not picked up the application yet. So SP will not be affected by this. Certainly if I'm wrong and we get news it will boost the SP if not negative.
2. FDA minutes - these won't tell us anything we don't already know so there will be no SP move either way when this arrives.
3. News on a partner - will rocket the SP if we get news. Won't affect if we don't get news before Christmas. No one has indicated when this news would come. Only way for this to be negative if they release RNS to say all talks have fallen through. Again, would love good news but not expecting anything pre x-mas. Only room for gain here pre Christmas.
4. I think the SP is quite close to having the dilution priced in so for the LTH this is only upward. I expect start drifting down in Jan if we don't see partner stump up, drift down will only go to 12 I would say but again for the LTH this is small stuff as once we raise funding and get some momentum it will rise significantly above that.
Crikey Bucolic - seriously flawed comparison.
So the Covid Vaccine added about 25billion dollar of market cap value to Pfizer using your SP's. Just reread that - 25 billion added to their company value. If we can achieve even 1% of that market value increase our share price would go to approx 140p. If that happens I'll pay homage to Ananda for his prescience. I'm pretty sure Ananda never claimed or would now claim that we were ever going to outperform a covid vaccine. If he did he would be claiming our SP would hit somewhere around £100................
So if our approval has 1% of the impact FUM sp will be 140p and we will be on the pigs back, maybe thats one reason you shouldn't be so gloomy.
Cricketmad I'm with you 100% on that. No one should be too disappointed by the delay in the transfer - if it happens in November I would say it was a good result as all admin is being substantially delayed with Covid.
Excuse my ignorance but when they say operational since early August and that they continue to fulfill pre purchase orders I assume that means regardless of handover we can expect the revenues to be significantly increased over H1 and the fact that staff levels are now @50% relative to H1 then expenses should also be significantly reduced. I know neither are game changers but at least our money lasts longer while we wait for the game changers to happen?